Canine Atopic Dermatitis

Canine atopic dermatitis.

Study details.

This study will evaluate the efficacy of a new treatment for canine atopic dermatitis.

Inclusion criteria:

Dog is at least 12 months of age and weighs at least 3 kgs or 6.6 lb

Dog is in overall good health and any underlying disease is stable

Dog has moderate pruritus, meets the minimum scores required for the study, and has a clinical diagnosis of atopic dermatitis

Dog has undergone all screening diagnostics which have ruled-out differential diagnoses

Owner agrees to maintain dog on an approved flea preventative for the duration of the study

Owner agrees to maintain dog on the same diet for the duration of the study

Dog does not have evidence of overt superficial or deep microbial skin infection (i.e. bacterial pyoderma or Malassezia dermatitis) at the time of study enrollment

Only one dog per household may be enrolled in this study

Owner is willing to comply with the study visit schedule and complete study-related activities

Exclusion criteria:

Dog is pregnant, lactating, or intended for use as a breeding animal

Dog is too aggressive or non-compliant to complete screening

Dog has evidence of malignant neoplasia, uncontrolled hypothyroidism, rickettsial disease, or
other condition that could affect immune function

Dog has evidence of fleas, ticks, mites, or other ectoparasites at the time of study enrollment

Dog is receiving or should be receiving systemic antimicrobial therapy for bacterial or fungal
dermatitis

Dog requires or is scheduled for vaccinations during the study

Dog does not meet minimum washout periods for excluded medications or minimal use or
frequency of use guidelines for conditionally approved medications

Dog had intradermal allergen testing less than 8 weeks prior to screening

Dog is owned by clinic personnel

Dog is currently enrolled in another clinical trial

Locations and contacts:

Duration of study.

6 visits over 112 days.

Covered costs.

All study-related costs are covered by the sponsor.